Insider Transactions in Q4 2019 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q4 2019)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 31
2019
|
Olivier Danos Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
302
+4.25%
|
$10,268
$34.82 P/Share
|